Company/Division name | Amgen |
Type of work | Manufacturing |
Reshoring category: | Reshoring |
Total number of jobs (added or to be added): | 400 |
Year reshoring announced: | 2021 |
Year reshoring implemented or to be implemented: | 2024 |
Domestically, the work will be done: | In-house |
Capital investment ($): | $365 |
City reshored to: | Columbus |
State(s) reshored to: | OH |
If relevant, work nearshored to: | - |
Industry(ies): | Medical Equipment & Supplies |
Product(s) reshored | vials, syringes |
What non-domestic negative factors made offshoring less attractive? | Total cost |
What domestic positive factors made reshoring more attractive? | Automation/technology, Eco-system synergies, Infrastructure, Skilled workforce availability/training |